Patent · US Expired

Histidine protein-phosphatase

US6812015B1 · kind B1 · utility

6Cited by

0References

9Claims

0Family size

Assignee

Merck Patentgesellschaft · DE

Inventors

Susanne Klumpp · Marburg, DE
Roland Kellner · Heppenheim, DE

Key dates

Filing date	Sep 4, 2001
Grant date	Nov 2, 2004
Priority date	—
Expiry date	Sep 4, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a novel enzyme, histidine protein phosphatase, which is derived from mammalian sources, and its homologue variants. The invention further relates to DNA sequences encoding said proteins, to a process for preparing the latter, and to antibodies directed against them. The novel phosphatase can be used for diagnosis of pathological states of cell regulation and cell growth and as pharmaceutical drug which can be administered in conjunction with pathological disorders related to malfunctions of said enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.